Press Release

Ablitech Launches New Web Site: Redesigned Look For All Backgrounds

Hattiesburg, Mississippi – Ablitech, Inc. CEO, Ken Malone, today unveiled a new and interactive web site that will allow the public to appreciate the value of a gene delivery system having the potential to save thousands of lives through stopping a number of cancers and degenerative diseases.

“From the moment you click on our site, you will have an immediate understanding of Ablitech’s mission and signature product –Versadel,” Malone said. 

The highly redesigned site features:  easier navigation, expanded product description and user-friendly layout.

“This new design was created specifically for our online audience that appeals to the general public, scientists, doctors and patients,” continued Malone. “The web site will help position Ablitech’s products, making it more attractive and accessible to a global audience of all backgrounds.”

Malone ended, “Moving forward, we will be updating and improving the site on a continual basis, using technology more efficiently to provide quick and direct access to our company.”

About Ablitech, Inc.: Ablitech, founded in 2006, is a Hattiesburg, Mississippi-based company that draws from the latest advances in polymer science and medicinal chemistry. Ablitech develops radical technologies for healing the human body. Ablitech's flagship product line, VersadelTM, is a technology that enables gene therapies for the treatment of all forms of cancer and other life threatening diseases.